Nelson M, Nelson D S, Spradbrow P B, Kuchroo V K, Jennings P A, Cianciolo G J, Snyderman R
Clin Exp Immunol. 1985 Jul;61(1):109-17.
Phenol-saline tumour extracts, active in the immunotherapy of bovine ocular squamous cell carcinoma (BOSCC), were used to immunize mice. The immunized mice became resistant to the depression of delayed type hypersensitivity (DTH) reactions by products of BOSCC cells or cultured mouse or rat tumour cells. They also showed partial resistance to the growth of an unrelated tumour. Monoclonal antibodies to a type C retrovirus protein, p15E, also induced resistance to the depression of DTH by products of BOSCC and mouse tumours. It is suggested that successful immunotherapy of BOSCC is associated with the induction of resistance to anti-inflammatory or immunosuppressive tumour cell products, allowing the operation of host defences, and that these products share antigenic determinants with a retrovirus protein.
在牛眼鳞状细胞癌(BOSCC)免疫治疗中具有活性的苯酚 - 盐水肿瘤提取物被用于免疫小鼠。免疫后的小鼠对BOSCC细胞产物或培养的小鼠或大鼠肿瘤细胞产物所导致的迟发型超敏反应(DTH)抑制具有抗性。它们还对无关肿瘤的生长表现出部分抗性。针对C型逆转录病毒蛋白p15E的单克隆抗体也诱导了对BOSCC和小鼠肿瘤产物所致DTH抑制的抗性。有人提出,BOSCC的成功免疫治疗与诱导对抗炎或免疫抑制肿瘤细胞产物的抗性相关,从而使宿主防御机制得以发挥作用,并且这些产物与一种逆转录病毒蛋白具有共同的抗原决定簇。